NDAORALTABLET
Approved
Jun 2007
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
47
Mechanism of Action
Angiotensin 2 Receptor Antagonists
Pharmacologic Class:
Angiotensin 2 Receptor Blocker
Clinical Trials (5)
Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric Patients
Started Aug 2011
12 enrolled
HypertensionChronic Kidney DiseaseNephrotic Syndrome
Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients
Started May 2010
564 enrolled
Hypertension
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.
Started Apr 2008
384 enrolled
Hypertension
Regression of Fatty Heart by Valsartan Therapy
Started Aug 2007
0Metabolic SyndromeLipotoxicity
Blood Pressure Lowering in Acute Stroke Trial (BLAST)
Started Aug 2007
0Cerebrovascular Accident